Tonix PharmaceuticalsTNXP
那斯達克 · USD
38.32
+0.64
(+1.70%)
盤中 08/02 02:28 (UTC+8)
08/02 02:28 (UTC+8)
Tonix PharmaceuticalsTNXP
38.32
+0.64
(+1.70%)
財務數據
損益表
- -
- -
- -
- 0.04
- 0.04
- 0.02
- 0.02
- 0.03
- 0.03
- 0.02
- -
- -
- -
- -
- -5.26
- -34.32
- -11.04
- 27.81
- -8.50
- -5.93
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 2,429 | 2,582 | 2,822 | 2,208 | 2,482 | 3,779 | 3,989 | - | - | - |
營業成本 | 943 | 1,183 | 1,555 | 3,367 | 1,660 | 2,367 | 2,374 | - | - | - |
營業毛利 | 1,486 | 1,399 | 1,267 | -1,159 | 822 | 1,412 | 1,615 | - | - | - |
營業費用 | 17,540 | 23,879 | 16,821 | 76,157 | - | 28,741 | 29,762 | 29,002 | 33,902 | 32,728 |
研發費用 | 7,436 | 8,297 | 9,114 | 9,698 | 12,863 | 17,120 | 21,048 | 21,976 | 26,511 | 24,674 |
推銷及管理費用 | 10,104 | 15,582 | 7,707 | 7,502 | 9,310 | 11,621 | 8,714 | 7,026 | 7,391 | 8,054 |
非經常性項目費用 | - | - | - | 58,957 | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -16,054 | -22,480 | -15,554 | -77,316 | -21,351 | -27,329 | -28,147 | -29,002 | -33,902 | -32,728 |
其他收入及費用 | -775 | 372 | 1,341 | -1,460 | 6,412 | 7 | 172 | 646 | 897 | 1,048 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -16,829 | -22,108 | -14,213 | -78,776 | -14,939 | -27,322 | -27,975 | -28,356 | -33,005 | -31,680 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -16,829 | -22,108 | -14,213 | -78,776 | -14,939 | -27,322 | -27,975 | -28,356 | -33,005 | -31,680 |
基本每股稅後盈餘(元) | -2.84 | -0.10 | -0.23 | -19.28 | -0.17 | - | -0.02 | -1.54 | -0.51 | -0.56 |
稀釋每股稅後盈餘(元) | -2.84 | 2.89 | 22.67 | -21.97 | -0.17 | -0.12 | -1.13 | -0.15 | -0.51 | -0.23 |
基本平均股數(千股) | 5927.00 | 226353.00 | 62122.00 | 4085.00 | 89235.00 | - | 1748985.00 | 18433.00 | 64178.00 | 61379.00 |
稀釋平均股數(千股) | 5927.00 | 226353.00 | 62122.00 | 4085.00 | 89235.00 | - | 1748985.00 | 18433.00 | 64178.00 | 61379.00 |
還原基本每股稅後盈餘(元) | -2.84 | -9.77 | -23.00 | -1928.00 | -535.72 | - | -51.18 | -4922.88 | -10272.00 | -11200.00 |
還原稀釋每股稅後盈餘(元) | -2.84 | 289.40 | 2267.00 | -2197.28 | -535.72 | -373.25 | -3602.00 | -473.00 | -10272.00 | -4576.00 |
還原基本平均股數(千股) | 5,927 | 2,263 | 621 | 40 | 27 | - | 546 | 5 | 3 | 3 |
還原稀釋平均股數(千股) | 5,927 | 2,263 | 621 | 40 | 27 | - | 546 | 5 | 3 | 3 |
EBITDA(千元) | -16,271 | -21,412 | -13,494 | -77,442 | -13,427 | -26,061 | -26,759 | -27,435 | -32,112 | -30,844 |